3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Triple Negative Breast Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Cancer Patients
1
Pancreatic Neoplasms
1
Locally Advanced Rectal Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Nivolumab
3
tivozanib
1
regorafenib
1
neratinib
1
lutetium Lu 177 dotatate
1
encorafenib
1
durvalumab
1
capivasertib
1
Valproic Acid
1
Thioctic Acid
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Gemcitabine
1
Fulvestrant
1
Folfox protocol
1
Fluorouracil
1
Cisplatin
1
Cetuximab
1
Bortezomib
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
camrelizumab
×
90 days
×
Clear all
No trials found.